Conclusions Telemonitoring interventions may be a better option than usual care in improving glycated haemoglobin control of patients with type 2 diabetes .
Aims This study evaluated clinical effectiveness of telemonitoring on the management of patients with type 2 diabetes .
Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes
OBJECTIVE To determine whether short-time , real-time continuous glucose monitoring ( RT-CGM ) has long-term salutary glycemic effects in patients with type 2 diabetes who are not on pr and ial insulin . RESEARCH DESIGN AND METHODS This was a r and omized controlled trial of 100 adults with type 2 diabetes who were not on pr and ial insulin . This study compared the effects of 12 weeks of intermittent RT-CGM with self-monitoring of blood glucose ( SMBG ) on glycemic control over a 40-week follow-up period . Subjects received diabetes care from their regular provider without therapeutic intervention from the study team . RESULTS There was a significant difference in A1C at the end of the 3-month active intervention that was sustained during the follow-up period . The mean , unadjusted A1C decreased by 1.0 , 1.2 , 0.8 , and 0.8 % in the RT-CGM group vs. 0.5 , 0.5 , 0.5 , and 0.2 % in the SMBG group at 12 , 24 , 38 , and 52 weeks , respectively ( P = 0.04 ) . There was a significantly greater decline in A1C over the course of the study for the RT-CGM group than for the SMBG group , after adjusting for covariates ( P < 0.0001 ) . The subjects who used RT-CGM per protocol ( ≥48 days ) improved the most ( P < 0.0001 ) . The improvement in the RT-CGM group occurred without a greater intensification of medication compared with those in the SMBG group . CONCLUSIONS Subjects with type 2 diabetes not on pr and ial insulin who used RT-CGM intermittently for 12 weeks significantly improved glycemic control at 12 weeks and sustained the improvement without RT-CGM during the 40-week follow-up period , compared with those who used only SMBG
Conclusions Telemonitoring interventions may be a better option than usual care in improving glycated haemoglobin control of patients with type 2 diabetes .
Aims This study evaluated clinical effectiveness of telemonitoring on the management of patients with type 2 diabetes .